Fatty liver disease

Diagnostic Histopathology

Volumn 20, Issue 3, 2014, Pages 102-108

  Petts, Gemma ^a   Lloyd, Kirsty ^a   Goldin, Robert ^a,b  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOCHROME P450; GAMMA GLUTAMYLTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; ALCOHOLIC FATTY LIVER; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; CELL VACUOLE; CLINICAL FEATURE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS; HISTOPATHOLOGY; HUMAN; INFLAMMATORY INFILTRATE; LIPOGRANULOMA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PREVALENCE; REVIEW; SYSTEMATIC REVIEW (TOPIC);

EID: 84897885061     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2014.01.008     Document Type: Review

References (37)

1. Obika M., Noguchi H. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res 2012, 2012:145754.
2. Blachier M., Leleu H., Peck-Radosavljevic M., Valla D.-C., Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. JHepatol 2013, 58:593-608.
3. Ekstedt M., Franzen L.E., Mathiesen U.L., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44:865-873.
4. Potts J.R., Verma S. Alcoholic hepatitis: diagnosis and management in 2012. Expert Rev Gastroenterol Hepatol 2012, 6:695-710.
5. Neuschwander-Tetri B.A., Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003, 37:1202-1219.
6. Levene A.P., Goldin R.D. The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology 2012, 61:141-152.
7. Anstee Q.M., Concas D., Kudo H., et al. Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. JHepatol 2010, 53:542-550.
8. Diab D.L., Yerian L., Schauer P., et al. Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. Clin Gastroenterol Hepatol 2008, 6:1249-1254. the official clinical practice journal of the American Gastroenterological Association.
9. Howlett D.C., Drinkwater K.J., Lawrence D., Barter S., Nicholson T. Findings of the UK national audit evaluating image-guided or image-assisted liver biopsy. Part II. Minor and major complications and procedure-related mortality. Radiology 2013, 266:226-235.
10. Michelotti G.A., Machado M.V., Diehl A.M. NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol 2013, 10:656-665.
11. O'Brien J., Powell L.W. Non-alcoholic fatty liver disease: is iron relevant?. Hepatol International 2012, 6:332-341.
12. Kleiner D.E., Brunt E.M. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis 2012, 32:3-13.
13. Patton H.M., Yates K., Unalp-Arida A., et al. Association betweenmetabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol 2010, 105:2093-2102.
14. Levene A.P., Kudo H., Armstrong M.J., et al. Quantifying hepatic steatosis- more than meets the eye. Histopathology 2012, 60:971-981.
15. Hall A.R., Dhillon A.P., Green A.C., et al. Hepatic steatosis estimated microscopically versus digital image analysis. Liver International 2013, 33:926-935. official Journal of the International Association for the Study of the Liver.
16. Guy C.D., Suzuki A., Burchette J.L., et al. Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease. Hum Pathol 2012, 43:790-800.
17. Levene A.P., Goldin R.D. Physiological hepatic nuclear vacuolation-how long does it persist?. Histopathology 2010, 56:426-429.
18. Itoh S., Yougel T., Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 1987, 82:650-654.
19. Caballero T., Gila A., Sanchez-Salgado G., et al. Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients. Histol Histopathol 2012, 27:459-466.
20. Pais R., Charlotte F., Fedchuk L., et al. Asystematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. JHepatol 2013, 59:550-556.
21. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
22. EASL clinical practical guidelines: management of alcoholic liver disease. JHepatol 2012, 57:399-420.
23. Edenberg H.J. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health 2007, 30:5-13. the journal of the National Institute on Alcohol Abuse and Alcoholism.
24. Thurman R.G., Ji S., Lemasters J.J. Alcohol-induced liver injury. The role of oxygen. Recent Dev Alcohol 1984, 2:103-117. an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.
25. Chedid A., Mendenhall C.L., Tosch T., et al. Significance of megamitochondria in alcoholic liver disease. Gastroenterology 1986, 90:1858-1864.
26. Brunt E.M. Histopathology of non-alcoholic fatty liver disease. Clin Liver Dis 2009, 13:533-544.
27. Spahr L., Rubbia-Brandt L., Genevay M., Hadengue A., Giostra E. Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis. BMC Gastroenterol 2011, 11:115.
28. Mathurin P., Duchatelle V., Ramond M.J., et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996, 110:1847-1853.
29. Mookerjee R.P., Lackner C., Stauber R., et al. The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. JHepatol 2011, 55:1103-1111.
30. Altamirano J., Miquel R., Katoonizadeh A., et al. Development and validation of a novel histological classification with prognostic value for alcoholic hepatitis. Hepatology 2011, 54:968A.
31. Galambos J.T. Natural history of alcoholic hepatitis. 3. Histological changes. Gastroenterology 1972, 63:1026-1035.
32. Theise N.D. Histopathology of alcoholic liver disease. Clin Liver Dis 2013, 2. An Official Learning Resource of AASLD.
33. Rockey D.C., Caldwell S.H., Goodman Z.D., Nelson R.C., Smith A.D. Liver biopsy. Hepatology 2009, 49:1017-1044.
34. Omary M.B., Ku N.O., Strnad P., Hanada S. Toward unraveling the complexity of simple epithelial keratins in human disease. JClin Invest 2009, 119:1794-1805.
35. Banner B.F., Savas L., Zivny J., Tortorelli K., Bonkovsky H.L. Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis. Am J Clin Pathol 2000, 114:860-866.
36. Zatloukal K., Stumptner C., Fuchsbichler A., et al. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002, 160:255-263.
37. Lackner C., Gogg-Kamerer M., Zatloukal K., Stumptner C., Brunt E.M., Denk H. Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. JHepatol 2008, 48:821-828.